Richard Wang has been named as chief executive of the joint venture, named Fosun Kite Biotechnology. Wang has extensive experience in the industry including roles at Procter & Gamble ...
Kite Pharma is flying high with the addition of a new member to its senior leadership team. Brian Heath has joined Gilead Sciences’ cell therapy subsidiary as a senior vice president and head of ...
Kite, a Gilead Sciences company, will share four posters that add to the growing body of evidence to support the clinical use of its chimeric antigen receptor (CAR) T-cell therapy portfolio, at the ...
Marking World Cancer Day 2025, this week's Executive Q&A is with Diego Santoro, General Manager & Head of International ...
U.S. Rep. April McClain Delaney visited Kite, a biopharmaceutical company that uses cell therapy to treat cancer, in Urbana on Thursday morning, one of several locations across her district she ...
Sartorius Stedim Biotech SA / Key word (s): Dividend Board of Directors of Sartorius Stedim Biotech resolves to propose dividend of 0.69 euros per share to Annual Shareholders’ Meeting 07-Feb-2025 ...
Richard Wang has been named as chief executive of the joint venture, named Fosun Kite Biotechnology. Wang has extensive experience in the industry including roles at Procter & Gamble ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback